No products in the cart.
Tag: acute lymphoblastic leukemia
KTE-X19 may induce remission in patients with relapsed or refractory B-cell lymphoblastic leukemia
1. 71% patients achieved complete remission or complete remission with incomplete recovery following KTE-X19 infusion. 2. The majority of adverse ...
Allogeneic anti-CD19 T cell therapy shows a manageable safety profile in pediatric and adult patients with high risk B-cell acute lymphoblastic leukemia
1. In two phase 1 studies, allogenic anti-CD19 CAR T cell (UCART19) treatment showed a manageable safety profile with relapsed ...
Acute lymphoblastic leukemia disease burden associated with safety and efficacy of CD19-CAR therapy
1. Patients with a higher disease burden of acute lymphoblastic leukemia (ALL) treated with CD19-specific chimeric antigen receptor (CAR) T ...
Rituximab improves survival in B-cell lineage acute lymphoblastic leukemia
1. Compared to standard chemotherapy alone, the addition of the rituximab significantly improves event-free survival among adults with CD20-positive, Philadelphia ...
Inotuzumab ozogamicin linked to better outcomes than standard chemotherapy for ALL: The INO-VATE ALL trial
1. Inotuzumab ozogamaxin (IO) demonstrated significantly higher complete remission rates and median progression-free survival compared to standard chemotherapy in relapsed ...
Risk factors for asparaginase-associated pancreatitis identified in patients with acute lymphoblastic leukemia
1. In a retrospective review of over 5000 children with acute lymphoblastic leukemia (ALL) who received asparaginase induction therapy, independent ...
2 Minute Medicine Rewind February 15, 2016
Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol Acute lymphoblastic ...
Patient Basics: Acute Lymphocytic Leukemia (ALL) in Adults
Originally published by Harvard Health. What Is It? Acute lymphocytic leukemia (ALL) is a type of leukemia. Leukemia is a ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.